Acurx Pharmaceuticals Inc. logo

Acurx Pharmaceuticals Inc.

ACXP | NASDAQ
Chart Builder DCF Calculator
$1.38
+$0.05 (+3.76%)
Sep 22, 2026, 11:31 AM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Cash & Equivalents
10.66M 9.25M 7.56M 5.91M 6.06M 4.64M 3.71M 5.76M 6.36M 8.92M 7.47M 7.05M 9.15M 7.18M 9.11M 10.61M 9.09M 11.08M 12.96M 14.46M 17.1M 2.63M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 50.25K n/a n/a n/a n/a 339.48K
Receivables
95.31K 56.31K 48.42K 40.21K 40.21K n/a 51.13K 97.37K 51.13K n/a 129.16K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
10.98M 9.54M 7.69M 6.11M 6.16M 4.81M 3.86M 5.98M 6.58M 9.11M 7.71M 7.16M 9.24M 7.39M 9.38M 10.95M 9.21M 11.32M 13.25M 14.99M 17.44M 2.64M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 50.25K n/a n/a n/a n/a 339.48K
Total Assets
10.98M 9.54M 7.69M 6.11M 6.16M 4.81M 3.86M 5.98M 6.58M 9.11M 7.71M 7.16M 9.24M 7.39M 9.38M 10.95M 9.26M 11.32M 13.25M 14.99M 17.44M 2.98M
Account Payables
3.83K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 16.63K
Other Current Liabilities
2.83M 24.67K 2.41M 52.71K 42.98K 21K 537.63K 247.21K 42.31K 21.42K 716.31K 206.81K 35.89K 20.39K 542.9K 296.66K 26.09K 15.63K 508.34K 252.12K 20.24K 30.19K
Total Current Liabilities
2.83M 2.53M 2.42M 2.47M 2.59M 2.49M 3.24M 3.32M 3.15M 3.11M 3.04M 3.22M 3.02M 2.07M 2.06M 1.18M 473.88K 633.03K 843.91K 712.44K 1.92M 460.8K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 49.88K
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 49.88K
Total Liabilities
2.83M 2.53M 2.42M 2.47M 2.59M 2.49M 3.24M 3.32M 3.15M 3.11M 3.04M 3.22M 3.02M 2.07M 2.06M 1.18M 473.88K 633.03K 843.91K 712.44K 1.92M 510.68K
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 66.5K
Book Value
8.15M 7.01M 5.27M 3.64M 3.57M 2.31M 615.12K 2.66M 3.43M 6M 4.67M 3.93M 6.22M 5.31M 7.32M 9.76M 8.79M 10.69M 12.41M 14.28M 15.52M 2.47M
Book Value Per Share
1.91 4.68 3.51 2.24 3 2.31 0.72 3.26 4.33 7.75 6.93 6.05 10.20 9.13 12.61 17.52 17.12 20.89 24.28 28.23 44.55 5.18
Common Stock
4.68K 3.39K 2.35K 1.8K 1.47K 22.4K 17.03K 16.77K 16K 15.76K 14.47K 13.01K 13.01K 11.67K 11.63K 11.59K 10.26K 10.26K 10.22K 10.13K 9.92K 17.75M
Retained Earnings
-79.22M -76.97M -75.29M -73.71M -71.72M -69.47M -67.32M -64.54M -61.72M -57.6M -53.22M -48.1M -44.99M -41.54M -38.64M -35.38M -31.84M -29.22M -26.55M -23.92M -19.28M -15.27M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -38.64M -35.38M -31.84M -29.22M -26.55M -23.92M -19.28M -15.27M
Shareholders Equity
8.15M 7.01M 5.27M 3.64M 3.57M 2.31M 615.12K 2.66M 3.43M 6M 4.67M 3.93M 6.22M 5.31M 7.32M 9.76M 8.79M 10.69M 12.41M 14.28M 15.52M 2.47M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.